GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus - PubMed (original) (raw)
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus
I Katona et al. Neuroscience. 2000.
Abstract
Cannabinoids have been shown to disrupt memory processes in mammals including humans. Although the CB1 neuronal cannabinoid receptor was identified several years ago, neuronal network mechanisms mediating cannabinoid effects are still controversial in animals, and even more obscure in humans. In the present study, the localization of CB1 receptors was investigated at the cellular and subcellular levels in the human hippocampus, using control post mortem and epileptic lobectomy tissue. The latter tissue was also used for [3H]GABA release experiments, testing the predictions of the anatomical data. Detectable expression of CB1 was confined to interneurons, most of which were found to be cholecystokinin-containing basket cells. CB1-positive cell bodies showed immunostaining in their perinuclear cytoplasm, but not in their somadendritic plasmamembrane. CB1-immunoreactive axon terminals densely covered the entire hippocampus, forming symmetrical synapses characteristic of GABAergic boutons. Human temporal lobectomy samples were used in the release experiments, as they were similar to the controls regarding cellular and subcellular distribution of CB1 receptors. We found that the CB1 receptor agonist, WIN 55,212-2, strongly reduced [3H]GABA release, and this effect was fully prevented by the specific CB1 receptor antagonist SR 141716A. This unique expression pattern and the presynaptic modulation of GABA release suggests a conserved role for CB1 receptors in controlling inhibitory networks of the hippocampus that are responsible for the generation and maintenance of fast and slow oscillatory patterns. Therefore, a likely mechanism by which cannabinoids may impair memory and associational processes is an alteration of the fine-tuning of synchronized, rhythmic population events.
Similar articles
- Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons.
Katona I, Sperlágh B, Sík A, Käfalvi A, Vizi ES, Mackie K, Freund TF. Katona I, et al. J Neurosci. 1999 Jun 1;19(11):4544-58. doi: 10.1523/JNEUROSCI.19-11-04544.1999. J Neurosci. 1999. PMID: 10341254 Free PMC article. - Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
Hájos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF. Hájos N, et al. Eur J Neurosci. 2000 Sep;12(9):3239-49. doi: 10.1046/j.1460-9568.2000.00217.x. Eur J Neurosci. 2000. PMID: 10998107 - Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.
Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF. Katona I, et al. J Neurosci. 2001 Dec 1;21(23):9506-18. doi: 10.1523/JNEUROSCI.21-23-09506.2001. J Neurosci. 2001. PMID: 11717385 Free PMC article. - Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition.
Hájos N, Freund TF. Hájos N, et al. Chem Phys Lipids. 2002 Dec 31;121(1-2):73-82. doi: 10.1016/s0009-3084(02)00149-4. Chem Phys Lipids. 2002. PMID: 12505692 Review. - The neurobiology and evolution of cannabinoid signalling.
Elphick MR, Egertová M. Elphick MR, et al. Philos Trans R Soc Lond B Biol Sci. 2001 Mar 29;356(1407):381-408. doi: 10.1098/rstb.2000.0787. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11316486 Free PMC article. Review.
Cited by
- Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.
Cortes-Briones J, Skosnik PD, Mathalon D, Cahill J, Pittman B, Williams A, Sewell RA, Ranganathan M, Roach B, Ford J, D'Souza DC. Cortes-Briones J, et al. Neuropsychopharmacology. 2015 Aug;40(9):2124-34. doi: 10.1038/npp.2015.53. Epub 2015 Apr 24. Neuropsychopharmacology. 2015. PMID: 25709097 Free PMC article. Clinical Trial. - Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.
Eggan SM, Stoyak SR, Verrico CD, Lewis DA. Eggan SM, et al. Neuropsychopharmacology. 2010 Sep;35(10):2060-71. doi: 10.1038/npp.2010.75. Epub 2010 Jun 16. Neuropsychopharmacology. 2010. PMID: 20555313 Free PMC article. - Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy.
Soltesz I, Alger BE, Kano M, Lee SH, Lovinger DM, Ohno-Shosaku T, Watanabe M. Soltesz I, et al. Nat Rev Neurosci. 2015 May;16(5):264-77. doi: 10.1038/nrn3937. Nat Rev Neurosci. 2015. PMID: 25891509 Free PMC article. Review. - Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.
Rea K, Roche M, Finn DP. Rea K, et al. Br J Pharmacol. 2007 Nov;152(5):633-48. doi: 10.1038/sj.bjp.0707440. Epub 2007 Sep 10. Br J Pharmacol. 2007. PMID: 17828292 Free PMC article. Review. - Dysfunctional prefrontal cortical network activity and interactions following cannabinoid receptor activation.
Kucewicz MT, Tricklebank MD, Bogacz R, Jones MW. Kucewicz MT, et al. J Neurosci. 2011 Oct 26;31(43):15560-8. doi: 10.1523/JNEUROSCI.2970-11.2011. J Neurosci. 2011. PMID: 22031901 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous